Appcelerator Closes $22 Million Financing Round to Accelerate Adoption of Mobile Engagement Platform

MOUNTAIN VIEW, CA–(Marketwired – Aug 25, 2014) – Appcelerator®
, provider of
the leading enterprise mobile engagement platform, today announced a $22 million
round of Series D funding led by new investor Rembrandt Venture Partners. Union
Grove Venture Partners, also a new investor, and existing investors Storm Ventures,
Sierra Ventures, Mayfield Fund, Translink Capital, Relay Ventures and EDB
Investments also participated in the round. Appcelerator will use the funding to increase
growth and accelerate adoption of its technology.

Appcelerator Closes $22 Million Financing Round to Accelerate Adoption of Mobile Engagement Platform Read More »

Flytxt partners with Smaato to offer ad monetization solutions for CSPs

Flytxt’s monetization service mADmart will enable CSPs to monetize their insight better
through Smaato’s RTB ad exchange that is connected to over 170 mobile DSPs and 100
ad networks; giving them instant access to global ad inventory including some of the largest
brands in the world like Times Internet Limited, ESPN CricInfo, NewsHunt and VuClip.

Flytxt partners with Smaato to offer ad monetization solutions for CSPs Read More »

Appcelerator and Microsoft Team Up to Connect Appcelerator Platform With Microsoft Azure Services

MOUNTAIN VIEW, CA, Aug 06, 2014 (Marketwired via COMTEX) —
Appcelerator, provider of the enterprise mobile engagement platform, has
teamed up with Microsoft to connect the Appcelerator Platform with Microsoft
Azure services. This will simplify the process of building fully native crossplatform apps powered by Azure.

Appcelerator and Microsoft Team Up to Connect Appcelerator Platform With Microsoft Azure Services Read More »

QT Vascular Seeks CE Mark Approval for Drug-Coated Version of Chocolate Balloon Catheter

Singapore, 24 July 2014 – Catalist-listed QT Vascular Ltd. (“QT Vascular” or together with its
subsidiaries, “the Group”), a developer and manufacturer of minimally invasive medical devices for the
treatment of vascular diseases, has applied for CE marking approval (“CE Mark”) with respect to the
Paclitaxel-Coated Chocolate®
Balloon Catheter (Chocolate Touch™)

QT Vascular Seeks CE Mark Approval for Drug-Coated Version of Chocolate Balloon Catheter Read More »